Sartorius BIA Separations

Sartorius BIA Separations develops and manufactures market-leading CIM® monolithic columns for the purification and analysis of large biomolecules such as viruses, plasmids, and mRNA, which are applied in cell and gene therapies. The company’s Cornerstone® biomanufacturing development services are the result of over 20 years of hands-on experience with the most challenging biopharmaceutical products, offering integrated process development solutions and new technologies designed to enhance the robustness and yield of large biomolecule production while improving the safety of therapeutic products. Sartorius BIA Separations’ manufacturing-scale purification technology has already been utilized in the production of the first commercialized advanced therapies; the company also has a significant presence in new drug candidates at the clinical development stage.